South Korea’s leading financial groups are racing to form stablecoin consortiums ahead of new legislation, but concerns persist over real-world demand and market competitiveness, with industry players eyeing partnerships with big tech and fintech firms to ensure viability.
#YonhapInfomax #Stablecoin #FinancialHoldingCompany #Consortium #SamsungGroup #DigitalAssetAct #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=102353
[Financial Sector Stablecoins] Diverging Strategies Among Financial Holding Companies Over Consortium Formation
South Korea’s leading financial groups are racing to form stablecoin consortiums ahead of new legislation, but concerns persist over real-world demand and market competitiveness, with industry players eyeing partnerships with big tech and fintech firms to ensure viability.
Yonhap InfomaxDS Investment & Securities’ Kim Soo-hyun is recognized for his independent research, providing critical analysis and actionable strategies on South Korea’s sweeping governance reforms and Samsung Group’s restructuring, earning his report the 2025 “Report of the Year.”
#YonhapInfomax #GovernanceReform #DSInvestmentSecurities #SamsungGroup #CommercialActAmendment #ShareholderValue #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=96730
[Report of the Year] DS Securities’ Kim Soo-hyun Charts Governance Upheaval
DS Investment & Securities’ Kim Soo-hyun is recognized for his independent research, providing critical analysis and actionable strategies on South Korea’s sweeping governance reforms and Samsung Group’s restructuring, earning his report the 2025 “Report of the Year.”
Yonhap InfomaxSamsung Group delivered record-breaking results in 2025, led by a semiconductor rebound and AI-driven growth, while resolving key legal risks and expanding its bio business, but faced ongoing challenges from industrial accidents and technology leaks.
#YonhapInfomax #SamsungGroup #Semiconductors #AI #BioBusiness #LegalRisksResolved #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=96532
[2025 Seven Major Groups Wrap-Up②] Samsung Marks Year of Semiconductor Rebound—Leads AI Power Race
Samsung Group delivered record-breaking results in 2025, led by a semiconductor rebound and AI-driven growth, while resolving key legal risks and expanding its bio business, but faced ongoing challenges from industrial accidents and technology leaks.
Yonhap InfomaxThe Samsung, CJ, and Shinsegae families marked the 38th anniversary of Samsung founder Lee Byung-chul's passing with separate memorial visits in Yongin, reflecting ongoing traditions and family dynamics.
#YonhapInfomax #SamsungGroup #LeeByungChul #CJGroup #MemorialService #FamilySuccession #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=91511
38th Memorial Service for Samsung Founder Lee Byung-chul Held in Yongin—Samsung Family Members Pay Respects Separately
The Samsung, CJ, and Shinsegae families marked the 38th anniversary of Samsung founder Lee Byung-chul's passing with separate memorial visits in Yongin, reflecting ongoing traditions and family dynamics.
Yonhap InfomaxSamsung Group will invest 450 trillion won ($338 billion) in South Korea over five years, up 25% from its previous plan, to expand semiconductor and AI capacity amid surging global demand.
#YonhapInfomax #SamsungGroup #Semiconductor #AIDemand #Investment #MemoryChips #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=91081
360 Trillion Won to 450 Trillion Won in Three Years—Samsung Bolsters Domestic Base to Meet Surging AI Demand
Samsung Group will invest 450 trillion won ($338 billion) in South Korea over five years, up 25% from its previous plan, to expand semiconductor and AI capacity amid surging global demand.
Yonhap Infomax
Samsung Biologics Rules Out Governance Restructuring Until 2030 Ahead of Spin-Off
Samsung Biologics has pledged not to pursue any governance restructuring or dual listings until 2030, easing market concerns over its upcoming spin-off and the broader Samsung Group ownership structure.
Yonhap InfomaxSamsung Group’s spin-off of Samsung Biologics is expected to give the conglomerate greater flexibility in addressing regulatory and governance challenges, particularly regarding cross-shareholdings and compliance with the proposed Samsung Life Law.
#YonhapInfomax #SamsungGroup #SamsungBiologics #CorporateGovernance #SpinOff #SamsungLifeLaw #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=66349
[Samsung Governance④] Samsung Expands Options to Address Corporate Structure Overhaul
Samsung Group’s spin-off of Samsung Biologics is expected to give the conglomerate greater flexibility in addressing regulatory and governance challenges, particularly regarding cross-shareholdings and compliance with the proposed Samsung Life Law.
Yonhap InfomaxNH Investment & Securities participates in major deals including Samsung Biologics' restructuring, showcasing strong partnership with Samsung Group and dominating first half's notable transactions in South Korea's financial sector.
#YonhapInfomax #NHInvestmentSecurities #SamsungBiologics #CorporateRestructuring #InvestmentBanking #SamsungGroup #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=64494
Samsung's Biotech Restructuring Aided by NH Securities - Sweeping Up First Half's Notable Deals
NH Investment & Securities participates in major deals including Samsung Biologics' restructuring, showcasing strong partnership with Samsung Group and dominating first half's notable transactions in South Korea's financial sector.
Yonhap Infomax
Samsung Bioepis Spin-off - Eyes on Group's Governance Restructuring
Samsung Biologics announces spin-off to create Samsung Epis Holdings, sparking speculation about potential broader Samsung Group governance restructuring amid biotech business reorganization.
Yonhap Infomax